Cite
HARVARD Citation
Chanchlani, N. et al. (n.d.). DOP62 Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy. Journal of Crohn's and colitis. pp. S097-S098. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chanchlani, N. et al. (n.d.). DOP62 Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy. Journal of Crohn's and colitis. pp. S097-S098. [Online].